Please login to the form below

Not currently logged in
Email:
Password:

GSK appoints new chief financial officer

GSK has announced that Julian Heslop will retire as chief financial officer at the end of March 2011 and will be replaced by Simon Dingemans
GlaxoSmithKline (GSK) has announced that Julian Heslop will retire from his role as chief financial officer (CFO) and executive director at the end of March 2011. He will be replaced by Simon Dingemans who will take up the roles of chief financial officer designate and executive director with effect from January 2011.



Simon Dingemans, new CFO at GSK

Simon Dingemans




Dingemans will join GSK from investment bank Goldman Sachs. During his 25 year career in investment banking, Dingemans has worked across multiple sectors including pharmaceuticals and consumer healthcare. Recently, he worked with GSK on their joint project with Pfizer to establish specialist HIV company ViiV Healthcare.


GSK CEO, Andrew Witty, said: "In joining our executive team, Simon will bring valuable experience and capability to support us in our strategy to grow and diversify GSK's business through organic means and bolt-on acquisitions. He will also be responsible for delivering cost savings from our global restructuring programme and implementing further measures to simplify our operational model. I am delighted that someone of his calibre will be joining GSK."

9th September 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics